Showing results (61-70 of 99) with videos related to
Sort By:
Pageof 10
Medicine and Science in Sports and Exercise|January 5, 2012
Effect of exercise on bone status and body composition in Japanese studentsKazuo Minematsu, Masanori Noguchi, Satoshi Muraki, et al.The Prostate|September 21, 2011
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapyMasanori Noguchi, Fukuko Moriya, Shigetaka Suekane, et al.The Prostate|May 7, 2004
Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancerMasanori Noguchi, Kyogo Itoh, Shigetaka Suekane, et al.International Journal of Oncology|January 17, 2009
Capability of SART3(109-118) peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 allelesElnisr Rashed Mohamed, Masayasu Naito, Yasunobu Terasaki, et al.Oncology Letters|March 20, 2015
Reduced expression of erythropoietin-producing hepatocyte B6 receptor tyrosine kinase in prostate cancerElnisr Rashed Mohamed, Masanori Noguchi, Ahmed Roshdi Hamed, et al.Experimental and Therapeutic Medicine|September 15, 2012
Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancerAkira Yamada, Masanori Noguchi, Nobukazu Komatsu, et al.Oncology Research|May 24, 2007
Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatmentMasanori Noguchi, Takashi Mine, Akira Yamada, et al.Oncology Letters|December 2, 2015
Assessment of cell proliferation in renal cell carcinoma using dual-phase 18F-fluorodeoxyglucose PET/CTRei Onishi, Masanori Noguchi, Hayato Kaida, et al.Asian Journal of Andrology|December 22, 2007
Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptomsMasanori Noguchi, Tatsuyuki Kakuma, Katsuro Tomiyasu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Tetsuro Sasada, et al.Pageof 10